Breast Cancer Drugs Market | Size | Share | Industry Analysis 2019-2025 | PBIGP

A research and development in Breast cancer treatment market

Breast cancer is a disease where uncontrolled growth of malignant cells in the breast tissue that is most commonly occurs in female than men. The common signs and symptoms associated with breast cancer include change in the breast shape, lumps in the breast, dimpling of skin, and red scaly patches on the skin. Treatment of breast cancer depends on various factors such as the type of breast cancer, the size of a tumor, stage of breast cancer and the grade of cancer cells. Breast cancer can be treated by various therapies such as radiation therapy, chemotherapy, hormone therapy, targeted therapy and bone-directed therapy.

Request sample Report: https://precisionbusinessinsights.com/request-sample?product_id=15801

The breast cancer commonly occurs due to drinking alcohol, being female, obesity, ionizing radiation, genetics and older age, etc. The breast cancer is diagnosed by taking a biopsy of lump. After the diagnosis, further tests are carried to determine the cancer stage and suitable treatment for the disease.

The global breast cancer therapy market is expected to increase with significant rate due to increasing breast cancer cases. Rising awareness about breast cancer stages and treatment, government initiatives, and improving healthcare infrastructure are driving the breast cancer therapeutics market. Furthermore, increased investments in R & D, development of targeted drug delivery systems, and advancement in cancer biology & pharmacology will boost the global breast cancer therapy market.

However, drug development challenges in developing countries, long-term side effects of drugs, high costs associated with drug development, stringent regulatory guidelines, and patent expiry of drugs might hamper the growth of breast cancer drugs market.
The global breast cancer therapy market is categorized on the basis of -
1. Drug class
• Anthracyclines
• Antimetabolites
• Epothilones
• Taxanes
• Alkylating agents
• Hormonal therapy
• Aromatase inhibitors
• Selective estrogen-receptor modulators
2. End-users
• Hospital, retail and online pharmacies

And lastly on the basis of geographical regions, the global breast cancer drugs market has five major regions- North America, Europe, Latin America, Middle East and Africa and Asia-Pacific. North America dominates the breast cancer diagnostics and drug technologies market due to increase cases of breast cancer disease, increase in old age female population, and favorable government initiatives for the treatment. Europe holds a major share in breast cancer treatment market owing to rise in the prevalence and incidence of breast cancer cases. Most of the pharmaceutical companies in breast cancer therapeutics market are focused on R & D, strategic collaborations, acquisitions & mergers, and product launches for the development in the breast cancer diagnostic and drug technologies market.

Some of the key players in breast cancer drugs market are AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Sanofi (France), Pfizer, Inc. (U.S.). Sun Pharmaceutical Industries Ltd (India), Actavis, Inc. (U.S.), Bayer AG (Germany), Teva Pharmaceutical Industries. Ltd. (Israel), Puma Biotechnology, Inc. (U.S.), and OncoGenex Pharmaceuticals Inc. (U.S.) to name a few. In 2017, U.S. FDA approved the Puma Biotechnology’s Nerlynx (Neratinib) for the treatment of HER2-positive breast cancer in early stage. And in the same year, AstraZeneca received an approval from European Commission (EC) for Faslodex (fulvestrant) for the breast cancer treatment.

For More Information: https://precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.